Ziftum 250mg/125mg Injection
Marketer
Bioheal Lifesciences Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ziftum 250mg/125mg Injection
Combiflam 250mg/125mg Injection, a dual-action antibiotic, combats bacterial infections by inhibiting microbial proliferation and preventing infection spread. Administration must be solely under medical supervision. Consistent adherence to the prescribed dosage is crucial; premature cessation may compromise efficacy. Complete the entire treatment regimen, even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek immediate medical attention for allergic reactions (skin rashes, itching, edema, respiratory distress). Inform your physician about all current medications, including over-the-counter drugs. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration support recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Primary Ingredients of Ziftum 250mg/125mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Ziftum 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ziftum 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ziftum 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ziftum 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ziftum 250mg/125mg Injection works:
Ziftum Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action stems from its disruption of bacterial cell wall synthesis, hindering their growth and survival. Sulbactam's role is to counteract bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ziftum 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ziftum 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences for fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Ziftum 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should cease until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ziftum 250mg/125mg Injection might induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Ziftum 250mg/125mg Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Ziftum 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage alterations for Ziftum 250mg/125mg Injection are not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ziftum 250mg/125mg Injection :
Should you forget a scheduled dose of Ziftum 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Ziftum 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently